Phase IV Multicenter, Prospective, Open-Label Clinical Trial of Cenegermin (rhNGF) for Stage 1 Neurotrophic Keratopathy (DEFENDO)

被引：0
|
作者：
Pedram Hamrah
Mina Massaro-Giordano
David Schanzlin
Edward Holland
Gregg Berdy
Giovanni Goisis
Georgea Pasedis
Flavio Mantelli
机构：
[1] Tufts University School of Medicine,Cornea Service, Department of Ophthalmology, Tufts Medical Center
[2] University of Pennsylvania,Scheie Eye Institute, Perelman School of Medicine
[3] Gordon Schanzlin New Vision Institute,undefined
[4] Cincinnati Eye Institute,undefined
[5] Ophthalmology Associates,undefined
[6] Dompé farmaceutici S.p.A.,undefined
[7] Dompé US,undefined
来源：
Ophthalmology and Therapy | 2024年 / 13卷
关键词：
Cenegermin; Corneal epithelial defect; Neurotrophic keratopathy; Neurotrophic keratitis; Recombinant human nerve growth factor; rhNGF; Stage 1 neurotrophic keratopathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：553 / 570
页数：17
相关论文
共 50 条
  • [1] Phase IV Multicenter, Prospective, Open-Label Clinical Trial of Cenegermin (rhNGF) for Stage 1 Neurotrophic Keratopathy (DEFENDO)
    Hamrah, Pedram
    Massaro-Giordano, Mina
    Schanzlin, David
    Holland, Edward
    Berdy, Gregg
    Goisis, Giovanni
    Pasedis, Georgea
    Mantelli, Flavio
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (02) : 553 - 570
  • [2] Use of itopride in the symptoms of functional dyspepsia in Russia: Results of a Phase IV prospective open-label multicenter clinical trial
    Kasyanenko, V. I.
    Denisov, N. L.
    Vasilyev, Yu. V.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (08) : 35 - 41
  • [3] Effectiveness and safety of morinidazole in the treatment of pelvic inflammatory disease: A multicenter, prospective, open-label phase IV trial
    Zhou, Ting
    Yuan, Ming
    Cui, Pengfei
    Li, Jingjing
    Jia, Feifei
    Wang, Shixuan
    Liu, Ronghua
    FRONTIERS IN MEDICINE, 2022, 9
  • [4] A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer
    Yan, Min
    Yuan, Peng
    Ouyang, Quchang
    Cheng, Ying
    Han, Guohui
    Wang, Dewei
    Ran, Li
    Sun, Tao
    Zhao, Da
    Bai, Yuju
    Yang, Shun'e
    Wang, Xiaojia
    Wu, Rong
    Zeng, Xiaohua
    Yao, Herui
    Ji, Xuening
    Jiang, Jun
    Hu, Xiaohua
    Lin, Haifeng
    Zheng, Liping
    Zhu, Zhitu
    Ge, Wei
    Yang, Junlan
    Cui, Tongjian
    Zhang, Xiaozhi
    Lu, Fangyang
    Li, Wenhui
    Xu, Hongyan
    Kang, Mafei
    Gong, Ping
    Zou, Liqun
    Liu, Jiang
    Zhang, Hongliang
    Yu, Hao
    Xu, Binghe
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [5] AN OPEN-LABEL MULTICENTER PHASE II TRIAL OF AVISCUMINE IN PREVIOUSLY TREATED PATIENTS WITH UNRESECTABLE STAGE IV METASTATIC MELANOMA
    Uwe, Trefzer
    Ralf, Gutzmer
    Tabea, Wilhelm
    Florian, Schenck
    Katharina, Kaehler C.
    Volkmar, Jacobi
    Klaus, Witthohn
    Hans, Lentzen
    Peter, Mohr
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S7 - S7
  • [6] PROSPECTIVE, MULTICENTER, OPEN-LABEL, NONRANDOMIZED TRIAL OF PAROMOMYCIN FOR CRYPTOSPORIDIOSIS IN AIDS
    RAMRATNAM, B
    FLANIGAN, TP
    GRAEBER, C
    HELLINGER, J
    SMITH, D
    TURNER, J
    CLINICAL RESEARCH, 1994, 42 (02): : A281 - A281
  • [7] A prospective, open-label, multicenter, phase IV clinical study on the safety and efficacy of lobaplatin in the treatment of metastatic breast cancer.
    Xu, Binghe
    Yan, Min
    Ouyang, Quchang
    Han, Guohui
    Cheng, Ying
    Wang, Dewei
    Li, Ran
    Zhao, Da
    Sun, Tao
    Bai, Yuju
    Yu, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Simultaneous resection of pancreatic cancer and liver oligometastases after induction chemotherapy in stage IV patients: An open-label prospective randomized multicenter phase III trial (CSPAC-1)
    Wei, M.
    Shi, S.
    Xu, J.
    Shen, B.
    Mou, Y.
    Qin, R.
    Fang, W.
    Chen, R.
    Wang, W.
    Shao, C.
    Yu, X.
    ANNALS OF ONCOLOGY, 2019, 30 : 318 - 318
  • [9] Safety and efficacy of IV treprostinil for pulmonary arterial hypertension - A prospective, multicenter, open-label, 12-week trial
    Tapson, VF
    Gomberg-Maitland, M
    McLaughlin, VV
    Benza, RL
    Widlitz, AC
    Krichman, A
    Barst, RJ
    CHEST, 2006, 129 (03) : 683 - 688
  • [10] A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa
    Amano, Masahiro
    Grant, Annika
    Kerdel, Francisco A.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (08) : 950 - 955
12345